within Pharmacolibrary.Drugs.R_RespiratorySystem.R03C_AdrenergicsForSystemicUse.R03CC09_Tretoquinol;

model Tretoquinol
  extends Pharmacolibrary.Drugs.ATC.R.R03CC09;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>R03CC09</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Tretoquinol is a selective beta-2 adrenergic agonist used as a bronchodilator for the treatment of asthma and other respiratory conditions. It is categorized under ATC code R03CC09. Tretoquinol is not widely approved or used in current clinical practice, and information about its clinical use is limited.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic data available for tretoquinol in humans, thus parameters reported here are estimated typical values for a beta-2 agonist administered orally to adults.</p><h4>References</h4><ol><li><p>Sugihara, J, et al., &amp; Harigaya, S (1988). Studies on intestinal lymphatic absorption of drugs. I. Lymphatic absorption of alkyl ester derivatives and alpha-monoglyceride derivatives of drugs. <i>Journal of pharmacobio-dynamics</i> 11(5) 369–376. DOI:<a href=\"https://doi.org/10.1248/bpb1978.11.369\">10.1248/bpb1978.11.369</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3171878/\">https://pubmed.ncbi.nlm.nih.gov/3171878</a></p></li><li><p>Camargo, FC, et al., &amp; Tobin, T (2006). Intravenous and intratracheal administration of trimetoquinol, a fast-acting short-lived bronchodilator in horses with &#x27;heaves&#x27;. <i>Equine veterinary journal</i> 38(6) 563–569. DOI:<a href=\"https://doi.org/10.2746/042516406x153355\">10.2746/042516406x153355</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/17124848/\">https://pubmed.ncbi.nlm.nih.gov/17124848</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Tretoquinol;
